Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa region.
Bazarbachi A, Azim HA, Alizadeh H, Aljurf M, Barista I, Chaudhri NA, Fahed Z, Fahmy OA, Ghavamzadeh A, Khalaf MH, Khatib S, Kutoubi A, Paydas S, Elayoubi HR, Zaatari G, Zawam HM, Zelenetz AD; MENA Lymphoma Regional Guidelines Committee. Bazarbachi A, et al. Among authors: barista i. J Natl Compr Canc Netw. 2010 Jul;8 Suppl 3:S29-35. doi: 10.6004/jnccn.2010.0122. J Natl Compr Canc Netw. 2010. PMID: 20697129
Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience.
Beköz H, Karadurmuş N, Paydaş S, Türker A, Toptaş T, Fıratlı Tuğlular T, Sönmez M, Gülbaş Z, Tekgündüz E, Kaya AH, Özbalak M, Taştemir N, Kaynar L, Yıldırım R, Karadoğan I, Arat M, Pepedil Tanrıkulu F, Özkocaman V, Abalı H, Turgut M, Kurt Yüksel M, Özcan M, Doğu MH, Kabukçu Hacıoğlu S, Barışta I, Demirkaya M, Köseoğlu FD, Toprak SK, Yılmaz M, Demirkürek HC, Demirkol O, Ferhanoğlu B. Beköz H, et al. Among authors: barista i. Ann Oncol. 2017 Oct 1;28(10):2496-2502. doi: 10.1093/annonc/mdx341. Ann Oncol. 2017. PMID: 28961828 Free article.
Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience.
Bekoz H, Ozbalak M, Karadurmus N, Paydas S, Turker A, Toptas T, Tuglular TF, Altuntas F, Cakar MK, Sonmez M, Gulbas Z, Demir N, Kaynar L, Yildirim R, Karadogan I, Arat M, Kapucu I, Aslan NA, Ozkocaman V, Turgut M, Yuksel MK, Ozcan M, Hacioglu SK, Barista I, Demirkaya M, Saydam G, Toprak SK, Yilmaz M, Demirkol O, Ferhanoglu B. Bekoz H, et al. Among authors: barista i. Ann Hematol. 2020 Nov;99(11):2565-2576. doi: 10.1007/s00277-020-04077-4. Epub 2020 Jun 7. Ann Hematol. 2020. PMID: 32507911 Clinical Trial.
Demographical and Clinical Features of Marginal Zone Lymphomas: A Retrospective Study of Turkish Oncology Group (TOG).
Türkkan G, Alkan A, Paydaş S, Tanrıverdi Ö, Karakaş Y, Karadurmuş N, Sakin A, Temiz S, Arpacı E, Akın M, Menekşe S, Şen CA, Barışta İ. Türkkan G, et al. Among authors: barista i. Indian J Hematol Blood Transfus. 2020 Oct;36(4):640-645. doi: 10.1007/s12288-020-01257-0. Epub 2020 Feb 22. Indian J Hematol Blood Transfus. 2020. PMID: 33100705 Free PMC article.
IPS-3 Validation in 1012 cases with classical hodgkin lymphoma.
Paydas S, Laçin S, Doğan M, Barista I, Yildiz B, Seydaoglu G, Karadurmus N, Civriz S, Kaplan MA, Yagci M, Gurkan E, Ercolak V. Paydas S, et al. Among authors: barista i. Leuk Res. 2021 Mar;102:106519. doi: 10.1016/j.leukres.2021.106519. Epub 2021 Jan 29. Leuk Res. 2021. PMID: 33556744
Easier and more explanatory indices by integrating leukocyte lymphocyte ratio (LLR) and prognostic nutritional index (PNI) to IPS systems in cases with classical Hodgkin lymphoma.
Paydas S, Lacin S, Dogan M, Barista I, Yildiz B, Seydaoglu G, Karadurmus N, Civriz S, Kaplan MA, Yagci M, Dincyurek HD, Ercolak V. Paydas S, et al. Among authors: barista i. Leuk Res. 2021 Aug;107:106586. doi: 10.1016/j.leukres.2021.106586. Epub 2021 Apr 24. Leuk Res. 2021. PMID: 34082249
Effectiveness of bendamustine in relapsed or refractory lymphoma cases: a Turkish Oncology Group study.
Karadurmus N, Paydas S, Esin E, Surmeli ZG, Yildiz B, Erturk I, Nayir E, Dogan M, Sumbul AT, Barista I, Gurkan E, Ocal R, Ferhanoglu B, Ozgur G, Karakas Y, Lacin S, Ozaydin S, Petekkaya HI, Uskent N. Karadurmus N, et al. Among authors: barista i. Arch Med Sci. 2019 Feb 18;17(4):920-927. doi: 10.5114/aoms.2019.83000. eCollection 2021. Arch Med Sci. 2019. PMID: 34336021 Free PMC article.
Treatment options in primary mediastinal B cell lymphoma patients, retrospective multicentric analysis; a Turkısh oncology group study.
Acar R, Paydaş S, Yıldırım M, Kılıçarslan E, Sahın U, Dogan A, Guven DC, Ekıncı O, Tıglıoglu M, Erdogan I, Elıbol T, Kızıloz H, Aykan MB, Sayın S, Kaptan K, Soydan E, Gokmen A, Esen R, Barısta I, Albayrak M, Erturk I, Yıldız B, Keskın GY, Aylı M, Karadurmus N. Acar R, et al. Among authors: barista i. J Cancer Res Ther. 2023 Apr;19(Supplement):S138-S144. doi: 10.4103/jcrt.jcrt_355_22. J Cancer Res Ther. 2023. PMID: 37147993 Free article.
102 results